Cochlear reported $12.71B in Market Capitalization this January of 2022, considering the latest stock price and the number of outstanding shares.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Market Capitalization Change
Ansell ANN:AU $ 5.57B 1.1B
Australian Pharma API:AU $ 549.31M 56.66M
Cochlear COH:AU $ 16.55B 4.12B
CSL CSL:AU $ 129.8B 957.74M
Estia Health EHE:AU $ 645.4M 182.91M
Fisher Paykel Healthcare FPH:NZ 17.94B 1.07B
Healius Ltd HLS:AU $ 2.88B 560.77M
Integral Diagnostics Ltd IDX:AU 1.03B 171.18M
Japara Healthcare JHC:AU 379.51M 214.03M
Mayne Pharma MYX:AU $ 564.75M 14.53M
Mesoblast MSB:AU $ 1.28B 37.65M
Monash IVF Group Ltd MVF:AU 331.19M 25.33M
Nanosonics Ltd NAN:AU $ 1.77B 647.82M
Opthea Ltd OPT:AU 468.59M 179.73M
Polynovo Ltd PNV:AU 1.87B 699.91M
Ramsay Health Care RHC:AU $ 14.41B 176.24M
Regis Healthcare REG:AU 586.52M 18.05M
ResMed RMD:AU $ 47.84B 10.68B
Sigma Healthcare Ltd SIG:AU 630.27M 21.23M
Somnomed Ltd SOM:AU 182.9M 9.1M
Sonic Healthcare SHL:AU $ 18.35B 2.99B
Telix Pharmaceuticals Ltd TLX:AU 1.71B 653.63M
Virtus Health VRT:AU 530.57M 102.9M